Picard Medical, Inc. - Asset Resilience Ratio
Picard Medical, Inc. (PMI) has an Asset Resilience Ratio of 20.80% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Picard Medical, Inc. for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Picard Medical, Inc.'s Asset Resilience Ratio has changed over time. See Picard Medical, Inc. (PMI) net assets for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Picard Medical, Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PMI stock market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $2.81 Million | 20.8% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $2.81 Million | 20.80% |
Asset Resilience Insights
- Good Liquidity Position: Picard Medical, Inc. maintains a healthy 20.80% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Picard Medical, Inc. Industry Peers by Asset Resilience Ratio
Compare Picard Medical, Inc.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 50.79% |
|
Sino Medical Sciences Technology In
SHG:688108 |
Medical Devices | 0.66% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
Annual Asset Resilience Ratio for Picard Medical, Inc. (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Picard Medical, Inc..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.79% | $96.00K | $12.11 Million | -1.35pp |
| 2023-12-31 | 2.15% | $244.00K | $11.37 Million | +1.16pp |
| 2022-12-31 | 0.98% | $152.00K | $15.44 Million | -- |
About Picard Medical, Inc.
Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internatio… Read more